Prolexys Pharmaceuticals ,Inc.
|Prolexys Pharmaceuticals ,Inc. Patent applications|
|Patent application number||Title||Published|
|20110123486||METHODS OF TREATING MULTIPLE MYELOMA AND RESISTANT CANCERS - Erastin analogs are useful in treating various cancers, particularly multiple myeloma. Erastin analogs are also useful in treating cancers that are resistant to other anticancer agents.||05-26-2011|
|20110092489||3-Aryl-Substituted Quinazolones, and Uses Thereof - Compounds represented by Structural Formula (I):||04-21-2011|
|20090214465||Quinoxaline Derivatives as Antitumor Agents - The invention relates to methods of screening for binding partners, especially binding partners essential for the biological activity of erastin (e.g. VDACs such as VDAC3). The invention also provides reagents and methods for effective killing of cancer cells with erastin and related compounds or derivatives.||08-27-2009|
|20090170834||Fused Pyrimidones and Thiopyrimidones, and Uses Thereof - Compounds represented by Structural Formula (I):||07-02-2009|
|20090136561||Non-peptidyl agents with pHSP20-like activity, and uses thereof - The present invention provides compositions and methods for modulating smooth muscle cells. The present invention also provides methods of identifying small molecule candidate therapeutic agents for modulating smooth muscle.||05-28-2009|
Patent applications by Prolexys Pharmaceuticals ,Inc.